1. Home
  2. NAMS vs HELE Comparison

NAMS vs HELE Comparison

Compare NAMS & HELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • HELE
  • Stock Information
  • Founded
  • NAMS 2019
  • HELE 1968
  • Country
  • NAMS Netherlands
  • HELE United States
  • Employees
  • NAMS N/A
  • HELE N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • HELE Home Furnishings
  • Sector
  • NAMS Health Care
  • HELE Consumer Discretionary
  • Exchange
  • NAMS Nasdaq
  • HELE Nasdaq
  • Market Cap
  • NAMS 1.7B
  • HELE 1.6B
  • IPO Year
  • NAMS N/A
  • HELE N/A
  • Fundamental
  • Price
  • NAMS $25.50
  • HELE $63.08
  • Analyst Decision
  • NAMS Strong Buy
  • HELE Buy
  • Analyst Count
  • NAMS 6
  • HELE 3
  • Target Price
  • NAMS $36.20
  • HELE $80.67
  • AVG Volume (30 Days)
  • NAMS 1.4M
  • HELE 395.0K
  • Earning Date
  • NAMS 02-06-2025
  • HELE 01-06-2025
  • Dividend Yield
  • NAMS N/A
  • HELE N/A
  • EPS Growth
  • NAMS N/A
  • HELE 5.17
  • EPS
  • NAMS N/A
  • HELE 6.03
  • Revenue
  • NAMS $33,594,000.00
  • HELE $1,929,883,000.00
  • Revenue This Year
  • NAMS $129.49
  • HELE N/A
  • Revenue Next Year
  • NAMS N/A
  • HELE $1.95
  • P/E Ratio
  • NAMS N/A
  • HELE $10.42
  • Revenue Growth
  • NAMS 78.77
  • HELE N/A
  • 52 Week Low
  • NAMS $10.50
  • HELE $48.05
  • 52 Week High
  • NAMS $27.29
  • HELE $127.83
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 62.30
  • HELE 31.74
  • Support Level
  • NAMS $24.40
  • HELE $66.06
  • Resistance Level
  • NAMS $26.95
  • HELE $75.68
  • Average True Range (ATR)
  • NAMS 1.66
  • HELE 2.25
  • MACD
  • NAMS 0.41
  • HELE -1.34
  • Stochastic Oscillator
  • NAMS 81.51
  • HELE 5.76

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home & Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty & Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

Share on Social Networks: